Pure Global

Pain and Hemodynamics in Peripheral Arterial Disease: Response to Pulsed Electromagnetic Treatment - Trial NCT06252181

Access comprehensive clinical trial information for NCT06252181 through Pure Global AI's free database. This phase not specified trial is sponsored by Ahram Canadian University and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06252181
Recruiting
other
Trial Details
ClinicalTrials.gov • NCT06252181
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Pain and Hemodynamics in Peripheral Arterial Disease: Response to Pulsed Electromagnetic Treatment
Pain and Hemodynamics in Peripheral Arterial Disease: Response to Pulsed Electromagnetic Treatment in Elderly

Study Focus

electromagnetic pulsed therapy

Interventional

other

Sponsor & Location

Ahram Canadian University

Giza, Egypt

Timeline & Enrollment

N/A

Dec 15, 2022

Mar 10, 2024

40 participants

Primary Outcome

ankle brachial index

Summary

patients with peripheral arterial disease are recommended to perform all exercise forms
 including elliptical type. electromagnetic treatment addition to exercise may increase
 benefits of this exercise

ICD-10 Classifications

Peripheral vascular disease, unspecified
Other peripheral vascular diseases
Other specified peripheral vascular diseases
Peripheral angiopathy in diseases classified elsewhere
Other congenital malformations of peripheral vascular system

Data Source

ClinicalTrials.gov

NCT06252181

Non-Device Trial